Degranulation
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
|
WikiDoc Resources for Degranulation | |
|
Articles | |
|---|---|
|
Most recent articles on Degranulation Most cited articles on Degranulation | |
|
Media | |
|
Powerpoint slides on Degranulation | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Degranulation at Clinical Trials.gov Trial results on Degranulation Clinical Trials on Degranulation at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Degranulation NICE Guidance on Degranulation
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Degranulation Discussion groups on Degranulation Patient Handouts on Degranulation Directions to Hospitals Treating Degranulation Risk calculators and risk factors for Degranulation
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Degranulation | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Degranulation is a cellular process that releases antimicrobial cytotoxic molecules from secretory vesicles called granules found inside some cells. It is used by several different cells involved in the immune system, including granulocytes (neutrophils, basophils and eosinophils) and Mast cells, and certain lymphocytes such as natural killer (NK) cells and cytotoxic T cells, whose main purpose is to destroy invading microorganisms.
Cytotoxic T cells and NK cells release molecules like perforin and granzymes by a process of directed exocytosis to kill infected target cells.[1]
Four kinds of granules exist in neutrophils that display differences in content and regulation. Secretory vesicles are the most likely to release their contents by degranulation, followed by gelatinase granules, specific granules, and azurophil granules.[2] [3]
Antigens interact with IgE molecules already bound to high affinity Fc receptors on the surface of mast cells to induce degranulation. The mast cell releases a mixture of compounds, including histamine, proteoglycans and serine proteases, from its cytoplasmic granules.[4]
In a similar mechanism, activated eosinophils release preformed mediators such as major basic protein, and enzymes such as peroxidase, following interaction between their Fc receptors and IgE molecules that are bound to large parasites like helminths.[5][6]
References
- ↑ Veugelers K, Motyka B, Frantz C, Shostak I, Sawchuk T, Bleackley R (2004). "The granzyme B-serglycin complex from cytotoxic granules requires dynamin for endocytosis". Blood 103 (10): 3845-53. PMID 14739229.
- ↑ Faurschou M, Borregaard N (2003). "Neutrophil granules and secretory vesicles in inflammation". Microbes Infect 5 (14): 1317-27. PMID 14613775.
- ↑ Lominadze G, Powell D, Luerman G, Link A, Ward R, McLeish K (2005). "Proteomic analysis of human neutrophil granules". Mol Cell Proteomics 4 (10): 1503-21. PMID 15985654.
- ↑ Yamasaki S, Saito T. "Regulation of mast cell activation through FcepsilonRI". Chem Immunol Allergy 87: 22-31. PMID 16107760.
- ↑ David J, Butterworth A, Vadas M (1980). "Mechanism of the interaction mediating killing of Schistosoma mansoni by human eosinophils". Am J Trop Med Hyg 29 (5): 842-8. PMID 7435788.
- ↑ Capron M, Soussi Gounni A, Morita M, Truong M, Prin L, Kinet J, Capron A (1995). "Eosinophils: from low- to high-affinity immunoglobulin E receptors". Allergy 50 (25 Suppl): 20-3. PMID 7677229.
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

